Table 2.
12-month prevalence of different anxiety and depressive disorders in participants who were toxoplasma seropositive or seronegative; calculated as predictive margins adjusting for age and sex
| Psychiatric disorder | Prevalence in T. gondii seropositive (% with 95% CI)1 | Prevalence in T. gondii seronegative (% with 95% CI)1 | P-value (Wald χ2) |
|---|---|---|---|
| Panic disorder | 2.4% (1.7%–3.6%) | 1.8% (1.4%–2.3%) | 0.17 |
| Agoraphobia | 0.5% (0.2%–1.1%) | 0.6% (0.4%–0.8%) | 0.88 |
| GAD | 1.9% (1.2%–3.0%) | 1.2% (0.9%–1.5%) | 0.04 |
| Social phobia | 1.5% (0.9%–2.6%) | 0.9% (0.7%–1.2%) | 0.09 |
| Any anxiety disorder | 5.1% (3.8%–6.6%) | 3.8% (3.3%–4.5%) | 0.08 |
| MDD | 5.0% (3.8%–6.6%) | 4.8% (4.2%–5.4%) | 0.75 |
| Dysthymia | 2.8% (2.0%–3.9%) | 2.3% (1.9%–2.8%) | 0.33 |
| Any depressive disorder | 6.8% (5.4%–8.6%) | 6.3% (5.6%–7.1%) | 0.53 |
| Both anxiety and depressive disorder | 2.5% (1.7%–3.8%) | 1.4% (1.1%–1.7%) | 0.01 |
| Alcohol use disorder | 4.3% (3.1%–6.0%) | 4.5% (4.0%–5.2%) | 0.76 |
1
Adjusted for age and sex